Last reviewed · How we verify
tamsulosin HCl
At a glance
| Generic name | tamsulosin HCl |
|---|---|
| Also known as | Omnic OCAS®, Flomax, silodosin Oral Capsule, Placebo-TH, Tamsulosin |
| Sponsor | Boehringer Ingelheim |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery (PHASE2)
- Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover Trial (PHASE4)
- Double j Stent Related Symptoms (EARLY_PHASE1)
- A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects (PHASE1)
- Study to Prevent Postoperative Urinary Retention (PHASE4)
- Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment (PHASE4)
- Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery (EARLY_PHASE1)
- Tamsulosin and the Risk of Serious Adverse Events
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |